Skip Content
You are currently on the new version of our website. Access the old version .
JCMJournal of Clinical Medicine
  • Correction
  • Open Access

30 May 2022

Correction: Di Micco et al. Clinical Differences between COVID-19 and a COVID-like Syndrome. J. Clin. Med. 2021, 10, 2519

,
,
,
,
,
,
and
1
Department of Medicine, Buonconsiglio Fatebenefratelli Hospital of Naples, 80122 Naples, Italy
2
Unit of Angiology, Department of Cardiac, Thoracic and Vascular Sciences, University Hospital of Padua, 35100 Padua, Italy
3
Department of Translational Medical Sciences, University of Campania “Luigi Vanvitelli”, 80131 Naples, Italy
4
Advanced Biochemistry Unit, Medylab, 80131 Naples, Italy
Incorrect Affiliation
In the published article [1], there was an error in the following affiliation: “Department of Translational Medical Sciences, Monaldi Hospital, University of Campania “Luigi Vanvitelli”, 80131 Naples, Italy”, it should have been “Department of Translational Medical Sciences, University of Campania “Luigi Vanvitelli”, 80131 Naples, Italy”.
Error in Table
In the original published article [1], there was a mistake in Table 1. The indexes in the scientific notation are missing. The corrected version appears below.
Table 1. Clinical characteristics of patients with COVID-like syndrome and typical COVID-19.
Table 1. Clinical characteristics of patients with COVID-like syndrome and typical COVID-19.
Sign/SymptomCOVID-like Patients
(n 50)
Typical COVID-19
(n 50)
p
Chills41/5039/500.7 *
Fever42/5036/500.2 *
Myalgia46/5035/505.6 × 10−3 **
Headache38/5031/500.1 *
Weakness45/5050/500.02 **
Anosmia14/5044/503.6 × 10−10 **
Lymphopenia (<1500 mmcube)49/5047/500.4 *
Increased CRP (>5 mg/dL)47/5050/500.09 *
Increased d-dimer (>500 µg/dL)36/5043/500.09 *
sO2 < 93%2/5046/501.4 × 10−21 **
Deep or superficial vein thrombosis0/503/500.09 *
Major bleeding1/502/500.7 *
Thromboprophylaxis with enoxaparin19/5050/502.9 × 10−12 **
Ischemic stroke or transient ischemic attack0/500/501 *
Critical limb ischemia0/500/501 *
Pneumonia with ground-glass opacities at chest CT-scan36/5050/504.8 × 10−5 **
Symptoms lasting > 14 days22/5023/500.09 *
IgM/IgG anti-SARS-CoV250/5050/501.00 *
* not statistically significant; ** statistically significant; CRP, C-reactive protein; sO2, oxygen saturation; IgM, immunoglobulin M; IgG, immunoglobulin G; CT, computerized tomography.
The authors apologize for any inconvenience that may have been caused, and state that the scientific conclusions are unaffected. The original article has been updated.

Reference

  1. Di Micco, P.; Camporese, G.; Russo, V.; Cardillo, G.; Imbalzano, E.; Tufano, A.; Bernardi, E.; Fontanella, A. Clinical Differences between COVID-19 and a COVID-Like Syndrome. J. Clin. Med. 2021, 10, 2519. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.